Blackrock 2037 Municipal Target Term Trust (BMN) Stock Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free BMN Stock Alerts $24.47 +0.15 (+0.62%) (As of 12:21 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsDividendFinancialsInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsInsider TradesOwnershipSEC FilingsShort InterestSocial Media Blackrock 2037 Municipal Target Term Trust Stock Price Performance5 Day Performance+1.12%1 Month Performance+1.00%3 Month Performance+1.06% Receive BMN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Blackrock 2037 Municipal Target Term Trust and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsCould this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. BMN Stock Chart for Wednesday, May, 8, 2024 BMN Chart by TradingView Blackrock 2037 Municipal Target Term Trust Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$24.12$24.32+0.83%$24.45$24.2532,663 shs$0.0005/06/2024$24.05$24.12+0.29%$24.24$24.1022,190 shs$0.0005/03/2024$23.94$24.05+0.46%$24.12$24.035,160 shs$0.0005/02/2024$24.10$23.94-0.66%$24.02$23.918,696 shs$0.0005/01/2024$24.06$24.10+0.17%$24.15$23.9919,716 shs$0.0004/30/2024$24.02$24.06+0.17%$24.15$24.009,608 shs$0.00 Get the Latest News and Ratings for BMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Blackrock 2037 Municipal Target Term Trust and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$23.97$24.02+0.21%$24.06$23.917,646 shs$0.0004/26/2024$23.87$23.97+0.42%$23.97$23.809,301 shs$0.0004/25/2024$23.91$23.87-0.17%$23.94$23.8417,565 shs$0.0004/24/2024$23.94$23.91-0.13%$24.00$23.8713,678 shs$0.0004/23/2024$23.80$23.94+0.59%$24.00$23.7620,762 shs$0.0004/22/2024$23.85$23.80-0.21%$24.00$23.7330,046 shs$0.0004/19/2024$23.85$23.85$23.95$23.7613,266 shs$0.0004/18/2024$23.83$23.85+0.08%$23.92$23.6811,986 shs$0.0004/17/2024$23.82$23.83+0.04%$23.85$23.6813,652 shs$0.0004/16/2024$23.90$23.82-0.33%$23.92$23.689,477 shs$0.0004/15/2024$23.96$23.90-0.25%$24.06$23.8018,317 shs$0.0004/12/2024$24.05$23.96-0.37%$24.04$23.924,800 shs$0.0004/11/2024$23.96$24.05+0.40%$24.08$23.9114,227 shs$0.0004/10/2024$24.07$23.96-0.48%$24.10$23.9013,474 shs$0.0004/09/2024$24.08$24.07-0.04%$24.15$24.052,919 shs$0.0004/08/2024$24.11$24.08-0.12%$24.08$24.007,842 shs$0.0004/05/2024$24.04$24.11+0.29%$24.11$23.9019,277 shs$0.0004/04/2024$23.99$24.04+0.21%$24.10$23.9215,768 shs$0.0004/03/2024$24.10$23.99-0.46%$24.09$23.9215,742 shs$0.0004/02/2024$24.09$24.10+0.04%$24.21$24.014,738 shs$0.0004/01/2024$24.11$24.09-0.08%$24.20$24.0513,014 shs$0.0003/29/2024$24.11$24.11$24.24$24.1135,993 shs$0.0003/28/2024$24.24$24.11-0.54%$24.24$24.1135,993 shs$0.0003/27/2024$24.24$24.24$24.24$24.2022,353 shs$0.0003/26/2024$24.20$24.24+0.17%$24.24$24.1323,338 shs$0.0003/25/2024$24.21$24.20-0.04%$24.24$24.0428,501 shs$0.0003/22/2024$24.17$24.21+0.17%$24.24$24.1519,905 shs$0.0003/21/2024$24.08$24.17+0.37%$24.24$23.9246,485 shs$0.0003/20/2024$24.02$24.08+0.25%$24.16$24.0023,356 shs$0.0003/19/2024$24.00$24.02+0.08%$24.10$23.9727,002 shs$0.0003/18/2024$23.95$24.00+0.21%$24.08$23.8831,096 shs$0.0003/15/2024$23.90$23.95+0.21%$23.99$23.8915,882 shs$0.0003/14/2024$24.13$23.90-0.95%$24.13$23.8523,393 shs$0.0003/13/2024$24.01$24.13+0.48%$24.14$23.9331,690 shs$0.00The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read03/12/2024$23.95$24.01+0.26%$24.05$23.9010,132 shs$0.0003/11/2024$23.90$23.95+0.21%$24.06$23.9025,233 shs$0.0003/08/2024$23.84$23.90+0.25%$23.96$23.8524,233 shs$0.0003/07/2024$23.89$23.84-0.21%$23.95$23.7721,908 shs$0.0003/06/2024$23.95$23.89-0.25%$23.93$23.7663,881 shs$0.0003/05/2024$23.89$23.95+0.25%$23.95$23.8212,372 shs$0.0003/04/2024$23.87$23.89+0.08%$23.96$23.7614,147 shs$0.0003/01/2024$23.82$23.87+0.21%$23.91$23.7219,300 shs$0.0002/29/2024$23.73$23.82+0.38%$23.82$23.7123,622 shs$0.0002/28/2024$23.58$23.73+0.64%$23.74$23.5527,539 shs$0.0002/27/2024$23.92$23.58-1.42%$24.03$23.5582,474 shs$0.0002/26/2024$24.02$23.92-0.42%$24.09$23.928,631 shs$0.0002/23/2024$24.00$24.00$24.15$23.996,703 shs$0.0002/22/2024$24.02$24.00-0.08%$24.20$24.0031,591 shs$0.0002/21/2024$24.05$24.02-0.12%$24.17$24.0015,746 shs$0.0002/20/2024$24.01$24.05+0.17%$24.22$24.0011,004 shs$0.0002/19/2024$24.01$24.01$24.13$23.9910,700 shs$0.0002/16/2024$24.04$24.01-0.12%$24.13$23.9910,794 shs$0.0002/15/2024$24.11$24.04-0.29%$24.17$24.0222,615 shs$0.0002/14/2024$24.02$24.11+0.37%$24.22$24.0318,526 shs$0.0002/13/2024$24.24$24.02-0.91%$24.14$24.0116,426 shs$0.0002/12/2024$24.09$24.24+0.62%$24.24$24.0814,012 shs$0.0002/09/2024$24.07$24.09+0.10%$24.22$23.9832,287 shs$0.0002/08/2024$24.18$24.07-0.48%$24.16$24.0414,284 shs$0.0002/07/2024$24.20$24.18-0.08%$24.39$24.1722,329 shs$0.00 Related Companies: Abrdn Global Dynamic Dividend Fund Stock Chart abrdn Global Premier Properties Fund Stock Chart Abrdn Healthcare Opportunities Fund Stock Chart Abrdn Income Credit Strategies Fund Stock Chart Abrdn World Healthcare Fund Stock Chart Advent Convertible and Income Fund Stock Chart AllianceBernstein National Municipal Income Fund Stock Chart Angel Oak Financial Strategies Income Term Trust Stock Chart Apollo Senior Floating Rate Fund Stock Chart Apollo Tactical Income Fund Stock Chart Receive BMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Blackrock 2037 Municipal Target Term Trust and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:BMN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blackrock 2037 Municipal Target Term Trust Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.